Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Change-Receivables" stands at 46.90 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.50 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 16.50 Billion Japanese Yens.
The 3 year change is -129.67 Billion Japanese Yens.
The 5 year change is 29.33 Billion Japanese Yens.
The 10 year change is 77.10 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |